Back to Evidence
Paper-scoped peptide mentionSequence reported

MR-22

PMC10847306::PEP000001

Source publication

The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli.

Frontiers in Cellular and Infection Microbiology · 2024

Sequence status
reported
Standardization
Sequence ready
Source location
unknown
Activity records
71

Sequence evidence

Reported molecular identity

MAKRRKKAKKKAKKAKKRRRRRNH

Table 1: MR-22 sequence MAKRRKKAKKKAKKAKKRRRRR-NH2, MW 2808.58, charge +17, purity 95.44%.

Resolved peptide links

Experimental observations

Records linked to this mention

AntimicrobialAntibacterialPositive observation
Record detail

Section 3.9: bacterial content in peritoneal lavage fluid of peritonitis mice treated with MR-22 decreased to 7.23 ± 0.36 Log10CFU/mL.

Measure
other
Value
7.23 ± 0.36 Log10CFU/mL
Target
Escherichia coli
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.